Form 4 for HBIO HARVARD BIOSCIENCE INC

Accepted 2021-07-12 00:00:00 ET · period of report 2021-07-08 · accession 0000921895-21-001842 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-07-12	2021-07-08	HBIO	Green James W	CEO, Dir	F - Tax	$8.03	-200.6K	2.23M	-8%	-$1.61M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-08	F	D	92,772	$8.03	2,139,900	D	—	—	(F3) The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 8, 2021. (F4) Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.
2	Common	Common Stock	2021-07-08	F	D	107,803	$8.03	2,232,672	D	—	—	(F1) The shares were disclosed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock award previously granted to the Reporting Person that vested in full on July 8, 2021. (F2) Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 842,012 shares of common stock beneficially owned by the Reporting Person.